Microbiome metabolome brain vagus nerve circuit in disease and recovery. (2022)

• Record Type: Book
• Further Information: Note: Elena L. Paley.
• Authors: Paley, Elena L
• Contents: 1. Introduction: Microbial metabolite interference of protein biosynthesis in neurodegenerative, neurodevelopmental, and other disorders; microbial metabolites hijacking vagus nerve 2. COVID-19: Scientific progress 1. Introduction: Tryptophan catabolism and tryptamine in viral infections 2. Hospital-acquired infections 3. COVID-19 and bacterial infections 4. COVID-19 in Florida 5. Possible sources of SARS-CoV-2 virus transmitting/dispersing: Leakage of untreated wastewater, medical procedure fecal microbiota transplantation, infected during insulin administration, animals, and other ways 6. COVID-19 and necrotizing medical conditions References 3. Viral-bacterial interactions in diseases 1. Virus-bacteria-fungi interactions, antimicrobial resistance, immune cross-reactivity, and autoimmunity 2. Viruses (SARS-CoV-2 and herpes simplex virus type 1) and bacteria in Alzheimer’s disease (AD) 3. Markers for blood-brain barrier (BBB) integrity: BBB integrity in Alzheimer’s disease 4. Viruses and bacteria in cardiovascular (CVD) and liver diseases References 4. Vagus nerve: Acid reflux, parietal cells, carpal tunnel syndrome, Alzheimer’s disease, COVID-19, stroke, cancer, and other diseases 1. Etiology and mechanisms of acid reflux development 2. Carpal tunnel syndrome (CTS), numbness or tingles, heartburn, and overuse of mobile electronic devices 3. Vagus nerve stimulation and rehabilitation 4. Conclusions References 5. Vagus nerve circuit: Microbiome—tryptophan metabolites—receptors and synapses 1. Gut dysbiosis and vagus nerve, gastroesophageal reflux disease 2. Vagus nerve and autonomic system, Arnold’s reflex 3. Vagus nerve in traditional Chinese medicine 4. Thyroid diseases, autonomic nervous system and vagus nerve 5. Vagus nerve: Receptors and neurotransmitters including glutamate, laryngopharyngeal reflux, gastroesophageal reflux and associated pulmonary diseases 6. Vagus nerve: Myelinated and unmyelinated axons and gut microbial tryptamine 7. Hypnosis: Vagus nerve and gut microbiome 8. Conclusions References 6. Glutamate and glutamate receptors in vagus nerve pathways and in Alzheimer’s disease 1. Glutamate, biogenic amines, and interaction with receptors 2. Glutamate and tryptamine under hypoxia and in protein biosynthesis 3. Glutamate (glutamic acid) in tRNA aminoacylation and protein biosynthesis 4. Glutamate in vagal nerve signaling 5. Conclusions References 7. Aminoacyl tRNA synthetase multiple forms in autoimmune and infectious diseases 1. Aminoacyl-tRNA synthetases in autoimmunity and COVID-19 2. Tryptophanyl-tRNA synthetase role in bacterial, viral, and parasitic infections 3. Tryptophanyl tRNA synthetase overexpression is procancer or anticancer? 4. Gut microbiome metabolites biogenic amines regulate enzymatic activities of aminoacyl-tRNA synthetases (ARS) in procancer and anticancer pathways and in inflammation 5. Conclusions References 8. Crystalized aromatic l-amino acid decarboxylase from bacteria Micrococcus percitreus catalyzing decarboxylation of tryptophan and l-DOPA (Levodopa or 3, 4-dihydroxy-l-phenylalanine) 1. Tryptamine, nociceptive withdrawal reflex, and vagus nerve 2. Purified and crystalized aromatic l-amino acid decarboxylase from Micrococcus percitreus 3. Bacteria Micrococcaceae in human 4. l-DOPA and dopamine in Parkinson’s disease (PD) 5. Other bacterial tyrosine decarboxylases 6. Conclusions References 9. Health effects of elevated CO2 levels, sparkling mineral water, seltzer carbonated water 1. Carbon dioxide and carbonation 2. Effects of CO2 in human are dose-dependent, wearing face masks 3. CO2 and panic attack 4. CO2-dependent bacteria 5. CO2 and vagal nerve 6. Conclusions References 10. Microbial antigens, allergies, and antibodies to microbial allergens: Significance of preexisting antibodies and stress for vaccination 1. Allergies and infections 2. Prevalence of allergy 3. Preexisting antibodies 4. Stress and hypnosis in health and disease 5. Conclusions References 11. Smell and taste identification deficits in disease 1. Vagus nerve: Olfactory and gustatory systems 2. Smell and taste disorders before COVID-19 era 3. COVID-19 and loss of smell and taste 4. Odor identification deficits in Alzheimer’s disease and aging 5. Allergies and olfactory dysfunction 6. Olfaction and gustation connection 7. Allergies and viral infections 8. Trace amine-associated receptors (TAARs) in organs with vagus nerve innervation and modulation 9. Conclusion References 12. Microorganisms producing biogenic amines: From food to human body 1. Sausages, different cheese varieties, honey, yogurt 2. Fungal pathogen Fusarium graminearum: From bread wheat pathogen to human clinical case References 13. Human genome or human microbiome genes: Which one is more important for human health and intellectual abilities? 1. From old dogma to human microbiome prior to birth 2. Tyramine inhibits tyrosine hydroxylase in intact tissues 3. Tyramine and blood-brain barrier (BBB) 4. What is the causative factor/s of the BBB subtle disruption in Parkinson’s disease (PD)? 5. Biogenic amines (trace amines): Metabolic changes in Parkinson’s disease 6. Humans possess human and microbial genes 7. Necrotizing enterocolitis, preterm birth, neurodevelopment, and vagus nerve 8. Conclusions References 14. Microorganisms used in agriculture, consumed from environment and associated with the edible raw fruits, vegetables, herbs, sprouts, and mushrooms 1. Plant microbiome 2. Microorganisms in herbs 3. Microorganisms in fruits, vegetables, and sprouts 4. Microorganisms in edible mushrooms 5. Microorganisms in agricultural practice 6. Conclusions References 15. Molecular and cell aggregation: Biogenic amines, proteins, platelets, and microbial pathogens 1. Tryptamine self-assembly with its metabolite in twofold helix 2. Biogenic amines in protein aggregation 3. Aggregation of human blood plasma platelets by tryptamine and other compounds 4. Aggregation of microbial pathogens 5. Tryptamine and airborne isocyanates 6. Conclusion References 16. Colonic diverticular disease as a risk factor for neurodegenerative and associated diseases 1. Diverticular disease: Picture of the disease 2. Medical conditions and diseases associated with diverticulosis and diverticulitis (diverticular disease) 3. Diverticular disease and vagal atrial fibrillation 4. Diverticular disease, colorectal cancer (CRC), cancer stem cells and role of tryptamine in “eat me” signal 5. Conclusions References 17. Alzheimer’s disease, dementia, aging, and COVID-19 1. Case series 2. Gut microbial tryptamine, serum albumin, SARS-CoV-2, and neurodegeneration 3. Polyamines in viral infection and Alzheimer’s disease 4. Gut microbiota, COVID-19, dementia, and biogenic amines 5. Tryptamine in viral infection 6. Meningitis and other diseases masquerading as Alzheimer's disease (misdiagnosed patients) 7. Conclusions References 18. Existing vaccines and new and old tools 1. General concepts of vaccination 2. Antibacterial vaccines 3. Antiviral vaccines 4. Antiparasite vaccines 5. Antiprotozoal vaccines 6. Antifungal vaccine 7. New antiinfectious approaches: Fight with mosquito-borne diseases 8. Targeting aminoacyl-tRNA synthetases: Antimicrobial development 9. Beneficial therapeutic property of ethnomedical extracts used in folk medicine 10. Conclusions References 19. Serotonin syndrome in neurodegenerative diseases and COVID-19: Mechanisms and consequences of intestinal infection 1. Tryptamine-induced serotonin syndrome and vagus nerve 2. Mechanisms of tryptamine-induced serotonin syndrome 3. Serotonin syndrome cases and neurodegenerative diseases 4. Serotonin syndrome cases and COVID-19 5. Conclusions References 20. Circulating cell-free mitochondria and membrane vesicles 1. Circulating cell-free mitochondria 2. Cell-free extracellular membrane vesicles 3. Cell-free mitochondrial DNA 4. Conclusions References 21. Protein synthesis inhibition in neuronal activities 1. Axonal transport, memory consolidation, neurite outgrowth 2. Mutations of genes encoding aminoacyl-tRNA synthetases and tRNAs 3. Beta-N-methylamino-l-alanine (BMAA) 4. Vagus nerve: Dietary protein, amino acids, and high-fat high-sugar diet 5. Conclusions References 22. Rosacea and associated medical disorders 1. Rosacea and associated neurodegenerative and other diseases 2. Rosacea, dental focal infections, and other focal infections 3. Rosacea and face mask 4. Vagus, facial, and trigeminal nerve communications: Human microbiome—Face interaction 5. Small intestinal bacterial overgrowth in rosacea 6. Altered vasculature in rosacea: Angiogenesis and vasodilation 7. Rosacea and cancer 8. Rosacea and acne 9. Chalazia pathology and lidocaine effects 10. Demodex: Hordeola and cancer 11. Rosacea: The
• Publisher Details: Amsterdam : Academic Press
• Publication Date: 2022
• Extent: 1 online resource
• Subjects: 612.89; Vagus nerve -- Diseases
• Languages: English
• ISBNs: 9780443151989
• Related ISBNs: 9780443191220
• Notes: Note: Description based on CIP data; resource not viewed.
• Access Rights: Legal Deposit; Only available on premises controlled by the deposit library and to one user at any one time; The Legal Deposit Libraries (Non-Print Works) Regulations (UK).
• Access Usage: Restricted: Printing from this resource is governed by The Legal Deposit Libraries (Non-Print Works) Regulations (UK) and UK copyright law currently in force.